Supplemental Figure legends
Supplemental Table S1. Demographic comparison of acute
asthmatics.
Supplemental Figure S1. Correlation analysis of
TXB2 with (A) FEV1, (B)
LTB4, (C) PGE2 and of (D) 15-HETE and
LTB4.
Supplemental Figure S2. Levels of (A) LTB4, (B)
LTE4, (C) Lipoxin A4 , and (D)
PGE2 in EBCs of asthmatic children at acute exacerbation
and convalescence stages.
Supplemental Figure S3. Levels of LTB4 (A),
LTE4 (B), Lipoxin A4 (C), and
PGE2 (D) during acute exacerbation (AE) and two weeks
after oral prednisolone treatment (C, convalescence) in asthmatic
subjects with the respective eicosanoid levels at the 30th percentile at
exacerbation. Each line represents each individual sample. Note: All
p-values are adjusted for multiple testing by Holm methods.
FA denotes the between-subjects main effect of
stratified eicosanoid levels during exacerbation; FBdenotes the within-subjects main effect of phasic change;
FAXB denotes the interaction of FA and
FB variables.